ASGCT 2026 x KACTUS

By Hannah Flaherty

May 5, 2026
Menu

Recent posts

KACTUS is excited to announce our participation in the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting—the premier global event for gene and cell therapy advancement. Taking place May 12–16, 2026, in Boston, Massachusetts, ASGCT brings together leading scientists, clinicians, and industry experts to share the latest breakthroughs in genetic medicines. With five days of scientific sessions, poster forums, and networking opportunities, it remains one of the most influential events shaping the future of gene and cell-based therapeutics.

What is the Protein Engineering & Cell Therapy Summit?

The American Society of Gene and Cell Therapy (ASGCT) Annual Meeting is the leading global event dedicated to advancing genetic and cellular medicines. It brings together pioneering scientists, clinicians, regulatory experts, and industry leaders to explore breakthroughs in gene editing, vector engineering, cell therapy, and translational research. Renowned for its scientific rigor and interdisciplinary collaboration, ASGCT serves as a cornerstone for innovation in next-generation therapeutics.

Event Overview 

Venue: Thomas M. Menino Convention & Exhibition Center, Boston, MA

Dates: May 12th to 16th

  • Conference Day 1: Monday, May 11, 2026 – 1:00 PM to 5:00 PM

  • Conference Day 2: Tuesday, May 12, 2026 – 8:00 AM to 6:30 PM

    • Exhibit Hall Open: 9:00 AM to 6:30 PM

  • Conference Day 3: Wednesday, May 13, 2026 – 8:00 AM to 6:30 PM

    • Exhibit Hall Open: 9:00 AM to 6:30 PM

  • Conference Day 4: Thursday, May 14, 2026 – 8:00 AM to 6:30 PM

    • Exhibit Hall Open: 9:00 AM to 6:30 PM

  • Conference Day 5: Friday, May 15, 2026 – 8:00 AM to 5:30 PM

Booth #1432

Posters

Poster #2194 Tailored AAV Solutions: AAV ELISA Kits and Customized Variant Kit Development 

Event Schedule 

ASGCT’s Annual Meeting is where science meets momentum in gene and cell therapy. From data-driven sessions to dynamic poster presentations and meaningful networking, the event offers a comprehensive view of the progress driving the field forward. Explore the week’s programming to discover the breakthroughs and discussions defining the future of genetic medicine.

Monday, May 11

  • Workshops (Separate Registration Required): 1:00 PM – 5:00 PM

Tuesday, May 12

  • Scientific Sessions and General Programming: 8:00 AM – 6:30 PM

  • Exhibit Hall Open: 9:00 AM – 6:30 PM

Wednesday, May 13

  • Scientific Sessions and General Programming: 8:00 AM – 6:30 PM

  • Exhibit Hall Open: 9:00 AM – 6:30 PM

Thursday, May 14

  • Scientific Sessions and General Programming: 8:00 AM – 6:30 PM

  • Exhibit Hall Open: 9:00 AM – 6:30 PM

Friday, May 15

  • Scientific Sessions and Closing Programming: 8:00 AM – 5:30 PM

About KACTUS

KACTUS specializes in the development and production of high-quality, bioactive recombinant proteins and enzymes that support innovation across antibody drug discovery, immunotherapy, gene therapy, and mRNA therapeutics. With a catalog of over 2,500 recombinant proteins spanning diverse targets, species, tags, and formats, we are committed to meeting the evolving needs of scientists in translational research. Our focus on rigorous quality control and reliable supply ensures the consistency and performance that today’s therapeutic development demands.

Featured Products 

Cell Therapy Products

Gene Editing Products

Recombinant Proteins